COMMUNIQUÉS West-GlobeNewswire
-
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
28/04/2026 -
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026 -
Financial and Strategic Review, Annual General Meeting, and Trading Halt
28/04/2026 -
Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
28/04/2026 -
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
28/04/2026 -
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
28/04/2026 -
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026 -
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
28/04/2026 -
Glass House Brands Reports Preliminary Unaudited First Quarter Financial Results, Updates FY2026 Guidance and Schedules Earnings Conference Call
28/04/2026 -
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
28/04/2026 -
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
28/04/2026 -
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
28/04/2026 -
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28/04/2026 -
Corza Medical Reaffirms Commitment to Gut Sutures Amid Changing Market Landscape
28/04/2026 -
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026 -
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026 -
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026 -
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026 -
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026
Pages